Phase 3 study of ridinilazole for the treatment of clostridium difficile infections.
Phase of Trial: Phase III
Latest Information Update: 06 Sep 2017
At a glance
- Drugs Ridinilazole (Primary)
- Indications Clostridium infections
- Focus Therapeutic Use
- 06 Sep 2017 According Summit Therapeutics, this trial is expected to commence in the first half of 2018.
- 06 Sep 2017 New trial record